Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 85, Issue 3 PART A, 2013, Pages 427-443

  Hadinoto, Kunn ^a   Sundaresan, Ajitha ^a   Cheow, Wean Sin ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Core shell nanoparticles; Drug delivery; Gene delivery; Hybrid nanoparticles; Lipid polymer; Liposomes

Indexed keywords

ANTIGEN; AROMATASE INHIBITOR; CAMPTOTHECIN; CISPLATIN; COMBRETASTATIN; DNA; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; INDIUM 111; LEVOFLOXACIN; LIPID POLYMER HYBRID NANOPARTICLE; LIPOFECTAMINE; MESSENGER RNA; NANOPARTICLE; PACLITAXEL; QUANTUM DOT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SINGLE CHAIN TUMOR NECROSIS FACTOR; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VMP001 ANTIGEN; YTTRIUM 90;

BIOCOMPATIBILITY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; COMPUTER ASSISTED TOMOGRAPHY; CRITICAL MICELLE CONCENTRATION; DIAGNOSTIC IMAGING; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; EMULSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; LARGE SCALE PRODUCTION; LIPID MEMBRANE; LIPID MONOLAYER; LIPID VESICLE; LIPOSOMAL DELIVERY; NANOENCAPSULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; REVIEW; SPRAY DRYING; STATIC ELECTRICITY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHOCHOLINE; 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-POLYETHYLENE GLYCOL; 1,2-DIOLEOYL-3-TRIMETHYLAMMONIUM-PROPANE; 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE; 1,2-DIPALMITOYL-3-TRIMETHYLAMMONIUM-PROPANE; 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-POLYETHYLENE GLYCOL; 3Β-[N-(N′,N′-DIMETHYLAMINOETHANE)-CARBAMYL] CHOLESTEROL; AUNC; BHEM-CHOL; CAMPTOTHECIN; CARCINOEMBRYONIC ANTIGEN; CEA; CHOL; CHOLESTEROL; CMT; COM; COMBRETASTATIN; COMPUTED TOMOGRAPHY; CORE SHELL NANOPARTICLES; CT; D-Α-TOCOPHEROL PEG 1000 SUCCINATE; DC-CHOL; DCX; DIETHYLENE-TRIAMINE-PENTAACETATE; DIMETHYL FORMAMIDE; DIMETHYL SULFOXIDE; DLPC; DMF; DMPE-PEG; DMSO; DOCETAXEL; DOPC; DOPE; DOTAP; DOX; DOXORUBICIN; DPPC; DPTAP; DRUG DELIVERY; DSPE-PEG; DTPA; ENHANCED PERMEABILITY AND RETENTION; EPR; FA; FA-OQLCS; FAP; FIBROBLAST ACTIVATION PROTEIN; FOLIC ACID; FOLIC ACID CONJUGATED OCTADECYL-QUATERNIZED LYSINE MODIFIED CHITOSAN; GENE DELIVERY; GFP; GOLD NANOCRYSTALS; GREEN FLUORESCENT PROTEIN; HCL; HYBRID NANOPARTICLES; HYDROGEN CHLORIDE; L/P; LIPID POLYMER; LIPID POLYMER NANOPARTICLES; LIPID TO POLYMER; LIPOSOMES; LPNS; MAGNETIC RESONANCE IMAGING; MAL-PEG-DSPE; MALEIMIDE-TERMINATED POLYETHYLENE GLYCOL 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE; MESSENGER RNA; METHOXY POLYETHYLENE GLYCOL-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE; METHOXY POLYETHYLENE GLYCOL-POLY(LACTIC ACID); MPEG-DSPE; MPEG-PLA; MRI; MRNA; N,N-BIS (2-HYDROXYETHYL)-N-METHYL-N-(2-CHOLESTERYLOXYCARBONYL AMINOETHYL) AMMONIUM BROMIDE; O/W; OIL-IN-WATER; PACLITAXEL; PARTICLE REPLICATION IN NON-WETTING TEMPLATES; PBAE; PBS; PC; PCX; PDI; PEG; PEG-OQLCS; PEG-PE; PEI; PET; PFBT; PHOSPHATE BUFFER SALINE; PHOSPHATIDYLCHOLINE; PLA; PLGA; POLY [(9,9-DIOCTYLFLUORENYL-2,7-DIYL)-CO-(1,4-BENZO-(2,1′,3) THIADIAZOLE)]; POLY Β-AMINO ESTER; POLY(ETHYLENE TEREPHTHALATE); POLY(ETHYLENEIMINE); POLY(LACTIC ACID); POLY(LACTIC-CO-GLYCOLIC ACID); POLY(VINYL ALCOHOL); POLYDISPERSITY INDEX; POLYETHYLENE GLYCOL; POLYETHYLENE GLYCOL CONJUGATED OCTADECYL-QUARTERNIZED LYSINE MODIFIED CHITOSAN; POLYETHYLENE GLYCOL-PHOSPHOETHANOLAMINE; PRINT; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PSMA; PVA; QD; QUANTUM DOTS; RBC; RE; RED BLOOD CELLS; REYNOLDS NUMBER; SCFV; SCTNF; SINGLE-CHAIN FV FRAGMENTS; SINGLE-CHAIN TUMOR NECROSIS FACTOR; SIRNA; SMALL INTERFERING RNA; TF; TNF; TPGS; TRANSFERRIN; TUMOR NECROSIS FACTOR; W/O/W; WATER-IN-OIL-IN-WATER;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LIPIDS; LIPOSOMES; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYMERS;

EID: 84888321603     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.07.002     Document Type: Review

References (97)

1. B.Y.S. Kim, J.T. Rutka, and W.C.W. Chan Current concepts: nanomedicine N. Engl. J. Med. 363 2010 2434 2443
2. K.S. Soppimath, D.C.W. Tan, and Y.Y. Yang PH-triggered thermally responsive polymer core-shell nanoparticles for drug delivery Adv. Mater. 17 2005 318 323
3. M.L. Hans, and A.M. Lowman Biodegradable nanoparticles for drug delivery and targeting Curr. Opin. Solid State Mater. Sci. 6 2002 319 327
4. A. Albanese, P.S. Tang, and W.C.W. Chan The effect of nanoparticle size, shape, and surface chemistry on biological systems Annu. Rev. Biomed. Eng. 14 2012 1 16
5. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
6. H.S. Yoo, and T.G. Park Folate receptor targeted biodegradable polymeric doxorubicin micelles J. Control. Release 96 2004 273 283
7. E.M. Enlow, J.C. Luft, M.E. Napier, and J.M. DeSimone Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings Nano Lett. 11 2011 808 813
8. J.J. Khandare, S. Jayant, A. Singh, P. Chandna, Y. Wang, N. Vorsa, and T. Minko Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel Bioconjug. Chem. 17 2006 1464 1472
9. H. Shmeeda, Y. Amitay, J. Gorin, D. Tzemach, L. Mak, J. Ogorka, S. Kumar, J.A. Zhang, and A. Gabizon Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells J. Control. Release 146 2010 76 83
10. Z. Xu, L. Chen, W. Gu, Y. Gao, L. Lin, Z. Zhang, Y. Xi, and Y. Li The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma Biomaterials 30 2009 226 232
11. E. Rosenthal, I. Poizot-Martin, T. Saint-Marc, J.-P. Spano, P. Cacoub, and T.D.S. Group Phase IV Study of liposomal daunorubicin (DaunoXome) in AIDS-related kaposi sarcoma Am. J. Clin. Oncol. 25 2002 57 59
12. M. Prabaharan, J.J. Grailer, S. Pilla, D.A. Steeber, and S. Gong Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery Biomaterials 30 2009 6065 6075
13. J.Q. Fan, G. Fang, X.D. Wang, F. Zeng, Y.F. Xiang, and S.Z. Wu Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles Nanotechnology 22 2011
14. V. Torchilin Multifunctional and stimuli-sensitive pharmaceutical nanocarriers Eur. J. Pharm. Biopharm. 71 2009 431 444
15. F.X. Gu, R. Karnik, A.Z. Wang, F. Alexis, E. Levy-Nissenbaum, S. Hong, R.S. Langer, and O.C. Farokhzad Targeted nanoparticles for cancer therapy Nano Today 2 2007 14 21
16. K. Cho, X. Wang, S. Nie, Z. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316
17. A. Puri, K. Loomis, B. Smith, J.H. Lee, A. Yavlovich, E. Heldman, and R. Blumenthal Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Crit. Rev. Ther. Drug Carrier Syst. 26 2009 523 580
18. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
19. D.E. Owens Iii, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102
20. H. Otsuka, Y. Nagasaki, and K. Kataoka PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 2003 403 419
21. Y. Sheng, C. Liu, Y. Yuan, X. Tao, F. Yang, X. Shan, H. Zhou, and F. Xu Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan Biomaterials 30 2009 2340 2348
22. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
23. N. Maurer, D.B. Fenske, and P.R. Cullis Developments in liposomal drug delivery systems Expert Opin. Biol. Ther. 1 2001 923 947
24. A. Gabizon, Y. Amitay, D. Tzemach, J. Gorin, H. Shmeeda, and S. Zalipsky Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models J. Control. Release 160 2012 245 253
25. I. Judson, J.A. Radford, M. Harris, J.Y. Blay, Q. van Hoesel, A. le Cesne, A.T. van Oosterom, M.J. Clemons, C. Kamby, C. Hermans, J. Whittaker, E. Donato di Paola, J. Verweij, and S. Nielsen Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group Eur. J. Cancer 37 2001 870 877
26. L. Zhang, J.M. Chan, F.X. Gu, J.-W. Rhee, A.Z. Wang, A.F. Radovic-Moreno, F. Alexis, R. Langer, and O.C. Farokhzad Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform ACS Nano 2 2008 1696 1702
27. J.M. Chan, L. Zhang, K.P. Yuet, G. Liao, J.-W. Rhee, R. Langer, and O.C. Farokhzad PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 30 2009 1627 1634
28. C. Salvador-Morales, L. Zhang, R. Langer, and O.C. Farokhzad Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups Biomaterials 30 2009 2231 2240
29. L.I. Zhang, and L. Zhang Lipid-polymer hybrid nanoparticles: synthesis, characterization and applications Nano LIFE 01 2010 163 173
30. B. Mandal, H. Bhattacharjee, N. Mittal, H. Sah, P. Balabathula, L.A. Thoma, and G.C. Wood Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform Nanomed.: Nanotechnol., Biol., Med. 2012
31. W. Hasan, K. Chu, A. Gullapalli, S.S. Dunn, E.M. Enlow, J.C. Luft, S. Tian, M.E. Napier, P.D. Pohlhaus, J.P. Rolland, and J.M. DeSimone Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer Nano Lett. 12 2011 287 292
32. Y. Kim, B. Lee Chung, M. Ma, W.J.M. Mulder, Z.A. Fayad, O.C. Farokhzad, and R. Langer Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices Nano Lett. 12 2012 3587 3591
33. J. Li, Y.Z. He, W. Li, Y.Z. Shen, Y.R. Li, and Y.F. Wang A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery Acta Pharmacol. Sin. 31 2010 509 514
34. J.J. Moon, H. Suh, M.E. Polhemus, C.F. Ockenhouse, A. Yadava, and D.J. Irvine Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine PLoS ONE 7 2012 e31472
35. A.J. Mieszawska, A. Gianella, D.P. Cormode, Y. Zhao, A. Meijerink, R. Langer, O.C. Farokhzad, Z.A. Fayad, and W.J.M. Mulder Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging Chem. Commun. 48 2012 5835 5837
36. P. Zhao, H. Wang, M. Yu, Z. Liao, X. Wang, F. Zhang, W. Ji, B. Wu, J. Han, H. Zhang, H. Wang, J. Chang, and R. Niu Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation Eur. J. Pharm. Biopharm. 81 2012 248 256
37. J.M. Chan, J.-W. Rhee, C.L. Drum, R.T. Bronson, G. Golomb, R. Langer, and O.C. Farokhzad In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles Proc. Natl. Acad. Sci. 108 2011 19347 19352
38. C.-M.J. Hu, L. Zhang, S. Aryal, C. Cheung, R.H. Fang, and L. Zhang Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform Proc. Natl. Acad. Sci. 2011
39. J. Thevenot, A.-L. Troutier, L. David, T. Delair, and C. Ladavière Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids Biomacromolecules 8 2007 3651 3660
40. L. Fenart, A. Casanova, B. Dehouck, C. Duhem, S. Slupek, R. Cecchelli, and D. Betbeder Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier J. Pharmacol. Exp. Ther. 291 1999 1017 1022
41. H. Wang, P. Zhao, W. Su, S. Wang, Z. Liao, R. Niu, and J. Chang PLGA/polymeric liposome for targeted drug and gene co-delivery Biomaterials 31 2010 8741 8748
42. A.-L. Troutier, T. Delair, C. Pichot, and C. Ladavière Physicochemical and interfacial investigation of lipid/polymer particle assemblies Langmuir 21 2005 1305 1313
43. S.K.E. Messerschmidt, A. Musyanovych, M. Altvater, P. Scheurich, K. Pfizenmaier, K. Landfester, and R.E. Kontermann Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells J. Control. Release 137 2009 69 77
44. S. Sengupta, D. Eavarone, I. Capila, G. Zhao, N. Watson, T. Kiziltepe, and R. Sasisekharan Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 436 2005 568 572
45. I. De Miguel, L. Imbertie, V. Rieumajou, M. Major, R. Kravtzoff, and D. Betbeder Proofs of the structure of lipid coated nanoparticles (SMBV™) used as drug carriers Pharm. Res. 17 2000 817 824
46. C.J. Hitzman, W.F. Elmquist, L.W. Wattenberg, and T.S. Wiedmann Development of a respirable, sustained release microcarrier for 5-fluorouracil I: in vitro assessment of liposomes, microspheres, and lipid coated nanoparticles J. Pharm. Sci. 95 2006 1114 1126
47. X.A. Li, N. Anton, C. Arpagaus, F. Belleteix, and T.F. Vandanune Nanoparticles by spray drying using innovative new technology: the Buchi Nano Spray Dryer B-90 J. Control. Release 147 2010 304 310
48. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 25 1999 471 476
49. X. Su, J. Fricke, D.G. Kavanagh, and D.J. Irvine In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles Mol. Pharm. 8 2011 774 787
50. X.-Z. Yang, S. Dou, Y.-C. Wang, H.-Y. Long, M.-H. Xiong, C.-Q. Mao, Y.-D. Yao, and J. Wang Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA ACS Nano 6 2012 4955 4965
51. Y. Zheng, B. Yu, W. Weecharangsan, L. Piao, M. Darby, Y. Mao, R. Koynova, X. Yang, H. Li, S. Xu, L.J. Lee, Y. Sugimoto, R.W. Brueggemeier, and R.J. Lee Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7α-APTADD to breast cancer cells Int. J. Pharm. 390 2010 234 241
52. G. Mittal, D.K. Sahana, V. Bhardwaj, and M. Kumar Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo J. Control. Release 119 2007 77 85
53. C. Clawson, L. Ton, S. Aryal, V. Fu, S. Esener, and L. Zhang Synthesis and characterization of lipid-polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol) shedding Langmuir 27 2011 10556 10561
54. P.K. Kandel, L.P. Fernando, P.C. Ackroyd, and K.A. Christensen Incorporating functionalized polyethylene glycol lipids into reprecipitated conjugated polymer nanoparticles for bioconjugation and targeted labeling of cells Nanoscale 3 2011 1037 1045
55. R.H. Fang, S. Aryal, C.-M.J. Hu, and L. Zhang Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method Langmuir 26 2010 16958 16962
56. P.M. Valencia, P.A. Basto, L. Zhang, M. Rhee, R. Langer, O.C. Farokhzad, and R. Karnik Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing ACS Nano 4 2010 1671 1679
57. T. Panagiotou, S.V. Mesite, and R.J. Fisher Production of norfloxacin nanosuspensions using microfluidics reaction technology through solvent/antisolvent crystallization Ind. Eng. Chem. Res. 48 2009 1761 1771
58. R.H. Fang, K.N.H. Chen, S. Aryal, C.-M.J. Hu, K. Zhang, and L. Zhang Large-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactor Langmuir 28 2012 13824 13829
59. W.S. Cheow, and K. Hadinoto Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles Colloids Surf. B 85 2011 214 220
60. A. Bershteyn, J. Chaparro, R. Yau, M. Kim, E. Reinherz, L. Ferreira-Moita, and D.J. Irvine Polymer-supported lipid shells, onions, and flowers Soft Matter 4 2008 1787 1791
61. Y. Liu, J. Pan, and S.-S. Feng Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance Int. J. Pharm. 395 2010 243 250
62. C. Chih-Hang, W. Yu-Chao, H. Hsin-Ying, W. Li-Chen, and Y. Chung-Shi Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications Nanotechnology 22 2011 185601
63. S.S. Feng, L.Y. Zhao, Z.P. Zhang, G. Bhakta, K.Y. Win, Y.C. Dong, and S. Chien Chemotherapeutic engineering: Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo Chem. Eng. Sci. 62 2007 6641 6648
64. W.S. Cheow, M.W. Chang, and K. Hadinoto The roles of lipid in anti-biofilm efficacy of lipid-polymer hybrid nanoparticles encapsulating antibiotics Colloids Surf. A - Physicochem. Eng. Aspects 389 2011 158 165
65. W.S. Cheow, and K. Hadinoto Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles Particuology 10 2012 327 333
66. Y.J. Wang, K. Kho, W.S. Cheow, and K. Hadinoto A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles Int. J. Pharm. 424 2012 98 106
67. Z. Wang, and P.C. Ho A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities Biomaterials 31 2010 7115 7123
68. J.M.L. Ebos, C.R. Lee, and R.S. Kerbel Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy Clin. Cancer Res. 15 2009 5020 5025
69. A.Z. Wang, K. Yuet, L. Zhang, F.X. Gu, M. Huynh-Le, A.F. Radovic-Moreno, P.W. Kantoff, N.H. Bander, R. Langer, and O.C. Farokhzad ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation Nanomedicine 5 2010 361 368
70. S.D. Kong, M. Sartor, C.M. Hu, W. Zhang, and W. Liang Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release Acta Biomater. 9 2013 5447 5452
71. S.D. Kong, W.Z. Zhang, J.H. Lee, K. Brammer, R. Lal, M. Karin, and S.H. Jin Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release Nano Lett. 10 2010 5088 5092
72. S. Aryal, C.-M.J. Hu, and L. Zhang Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy Mol. Pharm. 8 2011 1401 1407
73. A. Levchenko, B.M. Mehta, X. Niu, G. Kang, L. Villafania, D. Way, D. Polycarpe, M. Sadelain, and S.M. Larson Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells Proc. Natl. Acad. Sci. USA 102 2005 1933 1938
74. S. Aryal, C.-M.J. Hu, and L. Zhang Combinatorial drug conjugation enables nanoparticle dual-drug delivery Small 6 2010 1442 1448
75. S. Aryal, C.-M. Jack Hu, V. Fu, and L. Zhang Nanoparticle drug delivery enhances the cytotoxicity of hydrophobic-hydrophilic drug conjugates J. Mater. Chem. 22 2012 994 999
76. S. Kularatne, and P. Low Targeting of nanoparticles: folate receptor S.R. Grobmyer, B.M. Moudgil, Cancer Nanotechnology 2010 Humana Press 249 265
77. Y. Liu, K. Li, J. Pan, B. Liu, and S.-S. Feng Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel Biomaterials 31 2010 330 338
78. C.-M.J. Hu, S. Kaushal, H.S.T. Cao, S. Aryal, M. Sartor, S. Esener, M. Bouvet, and L. Zhang Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells Mol. Pharm. 7 2010 914 920
79. J.M. Chan, L. Zhang, R. Tong, D. Ghosh, W. Gao, G. Liao, K.P. Yuet, D. Gray, J.-W. Rhee, J. Cheng, G. Golomb, P. Libby, R. Langer, and O.C. Farokhzad Spatiotemporal controlled delivery of nanoparticles to injured vasculature Proc Natl Acad Sci 2010
80. A.L. Parker, C. Newman, S. Briggs, L. Seymour, and P.J. Sheridan Nonviral gene delivery: techniques and implications for molecular medicine Expert Rev. Mol. Med. 5 2003 1 15
81. S.H. Choi, S.-E. Jin, M.-K. Lee, S.-J. Lim, J.-S. Park, B.-G. Kim, W.S. Ahn, and C.-K. Kim Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells Eur. J. Pharm. Biopharm. 68 2008 545 554
82. I.-S. Kim, S.-K. Lee, Y.-M. Park, Y.-B. Lee, S.-C. Shin, K.C. Lee, and I.-J. Oh Physicochemical characterization of poly(l-lactic acid) and poly(d,l-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier Int. J. Pharm. 298 2005 255 262
83. C. Tros de Ilarduya, Y. Sun, and N. Düzgüneş Gene delivery by lipoplexes and polyplexes Eur. J. Pharm. Sci. 40 2010 159 170
84. M.S. Al-Dosari, and X. Gao Nonviral gene delivery: principle, limitations, and recent progress AAPS J. 11 2009 671 681
85. I. Papanicolaou, S. Briggs, and H.O. Alpar Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer J. Drug Target. 12 2004 541 547
86. E. Ambegia, S. Ansell, P. Cullis, J. Heyes, L. Palmer, and I. MacLachlan Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression Biochim. Biophys. Acta - Biomembr. 1669 2005 155 163
87. J. Heyes, L. Palmer, K. Chan, C. Giesbrecht, L. Jeffs, and I. MacLachlan Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA Mol. Ther.: J. Am. Soc. Gene Ther. 15 2007 713 720
88. Q. Zhong, D. Chinta, S. Pamujula, H. Wang, X. Yao, T. Mandal, and R. Luftig Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes J. Nanobiotechnol. 8 2010 6
89. Z. Li, and T.M. Rana Molecular mechanisms of RNA-triggered gene silencing machineries Acc. Chem. Res. 45 2012 1122 1131
90. S.C. Semple, A. Akinc, J. Chen, A.P. Sandhu, B.L. Mui, C.K. Cho, D.W. Sah, D. Stebbing, E.J. Crosley, E. Yaworski, I.M. Hafez, J.R. Dorkin, J. Qin, K. Lam, K.G. Rajeev, K.F. Wong, L.B. Jeffs, L. Nechev, M.L. Eisenhardt, M. Jayaraman, M. Kazem, M.A. Maier, M. Srinivasulu, M.J. Weinstein, Q. Chen, R. Alvarez, S.A. Barros, S. De, S.K. Klimuk, T. Borland, V. Kosovrasti, W.L. Cantley, Y.K. Tam, M. Manoharan, M.A. Ciufolini, M.A. Tracy, A. de Fougerolles, I. MacLachlan, P.R. Cullis, T.D. Madden, and M.J. Hope Rational design of cationic lipids for siRNA delivery Nat. Biotechnol. 28 2010 172 176
91. D.J. Gary, N. Puri, and Y.Y. Won Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery J. Control. Release 121 2007 64 73
92. S. Mishra, P. Webster, and M.E. Davis PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles Eur. J. Cell Biol. 83 2004 97 111
93. J. Shi, Z. Xiao, A.R. Votruba, C. Vilos, and O.C. Farokhzad Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery Angew. Chem. Int. Ed. 50 2011 7027 7031
94. C.F. Wu, C. Szymanski, and J. McNeill Preparation and encapsulation of highly fluorescent conjugated polymer nanoparticles Langmuir 22 2006 2956 2960
95. R.K. Shah, H.C. Shum, A.C. Rowat, D. Lee, J.J. Agresti, A.S. Utada, L.Y. Chu, J.W. Kim, A. Fernandez-Nieves, C.J. Martinez, and D.A. Weitz Designer emulsions using microfluidics Mater. Today 11 2008 18 27
96. B. Stark, G. Pabst, and R. Prassl Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure Eur. J. Pharm. Sci. 41 2010 546 555
97. M. Holzer, V. Vogel, W. Mantele, D. Schwartz, W. Haase, and K. Langer Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage Eur. J. Pharm. Biopharm. 72 2009 428 437